For the Quarter Ending March 2026
Bismuth Subsalicylate Prices in APAC
- In China, the Bismuth Subsalicylate Price Index rose by 5.66% quarter-over-quarter, supply tightening and exports.
- The average Bismuth Subsalicylate price for the quarter was approximately USD 31466.67/MT, reflecting March firming.
- Bismuth Subsalicylate Spot Price strengthened in March as smelter outages and thin inventories supported offers.
- Bismuth Subsalicylate Price Forecast indicates firmness as producers pass higher metal and salicylic feedstock costs.
- Bismuth Subsalicylate Production Cost Trend shows rising inputs from bismuth metal, salicylic acid pushing margins.
- Bismuth Subsalicylate Demand Outlook remains constructive as hospital tender front-loading and steady exports support offtake.
- Bismuth Subsalicylate Price Index volatility increased as logistics delays and emission controls constrained FOB availability.
- Finished API inventories tightened at Jiangsu hubs, boosting confidence and supporting domestic Price Index recovery.
Why did the price of Bismuth Subsalicylate change in March 2026 in APAC?
- Winter environmental inspections reduced bismuth smelter throughput, tightening feedstock supply and elevating manufacturer input costs.
- Salicylic-acid conversion costs rose due to coal-to-phenol margins and emission levies, increasing finished-API production expenses.
- Export enquiries from India and United States remained brisk, absorbing spot parcels and sustaining FOB momentum.
Bismuth Subsalicylate Prices in North America
- In United States, the Bismuth Subsalicylate Price Index fluctuated quarter-over-quarter in Q1 2026, driven by elevated production costs.
- The Bismuth Subsalicylate Production Cost Trend increased as the Producer Price Index rose 4.0% year-over-year in March 2026.
- Consumer Price Index inflation reached 3.3% year-over-year in March 2026, pushing up energy-intensive Bismuth Subsalicylate production expenses.
- The Bismuth Subsalicylate Demand Outlook strengthened because the Manufacturing Index expanded during the quarter ending March 2026.
- Retail sales grew 4.0% year-over-year in March 2026, sustaining downstream demand for Bismuth Subsalicylate -derived synthetic fibers.
- Industrial production increased 0.7% year-over-year in March 2026, providing baseline support for general chemical manufacturing needs.
- Byproduct sulfuric acid supply tightened as several nonferrous-metal smelters experienced planned maintenance periods in Q1 2026.
- Construction sector demand for Bismuth Subsalicylate derivatives showed mixed signals as multifamily housing starts surged in January 2026.
- The Bismuth Subsalicylate Price Forecast remained bullish throughout Q1 2026 due to sustained cost-push inflation and steady demand.
Why did the price of Bismuth Subsalicylate change in March 2026 in North America?
- Elevated input costs passed through the supply chain as the Producer Price Index rose in March 2026.
- The Manufacturing Index expanded in March 2026, driving higher consumption of highly reactive base chemical intermediates.
Bismuth Subsalicylate Prices in Europe
- In Germany, the Bismuth Subsalicylate Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream costs.
- The Consumer Price Index rose 2.7% while the Producer Price Index fell 0.2% in March 2026.
- The Manufacturing Index expanded in March 2026, despite industrial production remaining stagnant at 0.0% in February 2026.
- Retail sales grew 0.7% and unemployment hit 4.2% in February 2026, while consumer confidence reached -24.7 in March 2026.
- The Bismuth Subsalicylate Demand Outlook strengthened as downstream sector procurement increased in March 2026.
- Natural gas and electricity costs for Bismuth Subsalicylate processing plummeted in February 2026 before spiking in March 2026.
- The Bismuth Subsalicylate Price Forecast indicated upward pressure following tightened sulfuric acid precursor supply channels in March 2026.
Why did the price of Bismuth Subsalicylate change in March 2026 in Europe?
- Natural gas and electricity energy production costs spiked sharply for industrial producers in March 2026.
For the Quarter Ending December 2025
Bismuth Subsalicylate Prices in APAC
- In China, the Bismuth Subsalicylate Price Index rose by 6.36% QoQ, driven by pharmaceutical demand firming.
- The average Bismuth Subsalicylate price for the quarter was approximately USD 29780.00/MT, reflecting Q4 stability overall.
- Bismuth Subsalicylate Spot Price firmed as exporters held offers while Shanghai inventories tightened amid winter maintenance.
- Bismuth Subsalicylate Price Forecast suggests modest monthly gains driven by steady hospital tenders and export inquiries.
- Bismuth Subsalicylate Production Cost Trend rose with firmer refined bismuth metal quotations increasing formulators' input expenses.
- Bismuth Subsalicylate Demand Outlook remains constructive as OTC growth and export contract volumes support ongoing procurement.
- Bismuth Subsalicylate Price Index registered measured upward bias while inventories shortened and buying remained disciplined overall.
- Winter inspections and maintenance trimmed refined availability modestly, yet rail and port logistics avoided significant disruptions.
Why did the price of Bismuth Subsalicylate change in December 2025 in APAC?
- Supply disruptions and maintenance reduced immediate availability, tightening spot markets and supporting marginal upward price pressure locally.
- Firmer refined bismuth metal quotations increased production costs, influencing formulators' offers and sustaining FOB Shanghai pricing margins.
- Hospital tender deliveries and export contract shipments maintained steady offtake, preventing notable destocking and stabilizing market fundamentals.
Bismuth Subsalicylate Prices in North America
- In the USA, the Bismuth Subsalicylate Price Index rose modestly quarter-over-quarter, reflecting firm pharmaceutical demand from OTC and hospital segments.
- The average Bismuth Subsalicylate price for the quarter remained stable, supported by limited domestic supply and continued procurement by pharmaceutical formulators.
- Bismuth Subsalicylate Spot Price strengthened in Q4 as inventories at key distribution centers tightened, while producers maintained disciplined offers.
- Bismuth Subsalicylate Production Cost Trend increased due to higher refined bismuth metal costs, influencing formulation and pricing strategies.
- Bismuth Subsalicylate Demand Outlook remains robust, underpinned by steady OTC sales, hospital tenders, and some export contract volumes.
- In September 2025, the Price Index increased owing to tighter refined bismuth availability and restocking by pharmaceutical distributors ahead of seasonal demand.
- Bismuth Subsalicylate Price Forecast anticipates moderate upward pressure in the near term, supported by stable downstream procurement and ongoing cost pressures.
- Price Index movements were influenced by inventory drawdowns, selective spot purchases, and continuous hospital and OTC demand, keeping the market moderately firm.
Bismuth Subsalicylate Prices in Europe
- In Germany, France, and Italy, the Bismuth Subsalicylate Price Index rose quarter-over-quarter, supported by pharmaceutical and OTC demand for gastrointestinal formulations.
- Average prices remained firm as spot availability tightened, reflecting production and logistics constraints.
- Bismuth Subsalicylate Spot Price strengthened as distributors competed for limited cargoes, while integrated producers maintained steady operating rates.
- Bismuth Subsalicylate Production Cost Trend saw modest increases, largely due to higher refined bismuth metal quotations impacting formulation costs.
- Bismuth Subsalicylate Demand Outlook stayed constructive, driven by seasonal uptick in OTC gastrointestinal products and ongoing hospital contracts.
- In September 2025, the Price Index increased as European buyers replenished inventories post-summer and refined bismuth supply tightened.
- Bismuth Subsalicylate Price Forecast suggests stable to slightly bullish trends in the short term, depending on feedstock pricing and export allocation.
- Price Index volatility remained limited due to steady logistics, disciplined producer offers, and measured downstream restocking, preventing sharp price swings.
For the Quarter Ending September 2025
North America
- In United States, the Bismuth Subsalicylate Price Index rose quarter-over-quarter in Q3 2025, driven by robust demand and rising production costs.
- Production costs increased due to a 2.6% year-over-year PPI rise in August 2025, impacting raw materials and operational expenses.
- Demand outlook remained strong, supported by a 5.42% retail sales increase and low 4.3% unemployment in September 2025.
- Consumer-level inflation, indicated by a 3.0% CPI increase year-over-year in September 2025, raised overall operational expenses.
- The pharmaceutical sector experienced notably increased FDA drug approvals in Q3 2025, boosting demand for active ingredients.
- Chemical inventories in the US shrank in Q3 2025, with raw materials inventory levels contracting due to destocking efforts.
- US chemical production activity appeared to contract in Q3 2025, with more firms reporting declining output levels.
Why did the price of Bismuth Subsalicylate change in September 2025 in North America?
- Rising production costs were driven by a 2.6% year-over-year PPI increase in August 2025.
- Strong consumer spending, evidenced by a 5.42% retail sales increase in September 2025, boosted demand.
- Shrinking chemical inventories in Q3 2025, coupled with contracting US chemical production, tightened supply.
APAC
- In China, the Bismuth Subsalicylate Price Index rose quarter-over-quarter in Q3 2025.
- Production costs for Bismuth Subsalicylate rose in Q3 2025 due to moderate upward pressure on salicylic acid feedstock in the quarter.
- Demand for Bismuth Subsalicylate was sustained by China's thriving pharmaceutical market and aging population.
- Retail sales increased 3.0% year-over-year in September 2025, yet consumer confidence remained low (89.6 index).
- Industrial production expanded 6.5% year-over-year in September 2025, indirectly supporting economic stability.
- Persistent oversupply in global chemical markets, including China, pressured Bismuth Subsalicylate prices downward.
- Chinese salicylic acid manufacturers tightened operating rates in Q3 2025 due to environmental inspections, curtailing supply.
Why did the price of Bismuth Subsalicylate change in September 2025 in APAC?
- Declining PPI (-2.3% YoY in September 2025) reduced input costs for Bismuth Subsalicylate production.
- Persistent oversupply in China's chemical markets during Q3 2025 exerted downward pressure on prices.
- Upward pressure on salicylic acid feedstock costs and energy tariffs increased production expenses.
Europe
- In Germany, Bismuth Subsalicylate Price Index rose in Q3 2025, due to surging raw material costs and tightened inventories.
- Production costs faced upward pressure in Q3 2025, despite a 1.7% PPI decrease in September.
- Demand for Bismuth Subsalicylate showed sustained growth in Q3 2025, supported by increased pharmaceutical manufacturing output.
- The Bismuth Subsalicylate price forecast indicates a firm trend, influenced by supply constraints and stable pharmaceutical demand.
- Germany's Manufacturing Index was contracting in Q3 2025; industrial production declined 1.0% in September.
- European natural gas prices moderated in Q3 2025, yet bismuth raw material costs surged due to export restrictions.
- Global bismuth inventories tightened significantly in Q3 2025, while German exports contracted.
- Consumer Price Index rose 2.4% in September 2025, impacting purchasing power; retail sales increased 0.2%.
Why did the price of Bismuth Subsalicylate change in September 2025 in Europe?
- Bismuth raw material costs surged in Q3 2025, driven by export restrictions and supply constraints.
- Global bismuth inventories tightened significantly in Q3 2025, following major stockpile depletion.
- Sustained German pharmaceutical demand, with retail sales up 0.2% in September 2025, supported prices.
